MIR-21-5P and MIR-146A-5P are deregulated in inflamed terminal ileum of treatment-naive pediatric patients with Crohn's disease
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F19%3A00071766" target="_blank" >RIV/65269705:_____/19:00071766 - isvavai.cz</a>
Result on the web
<a href="https://academic.oup.com/ibdjournal/article-abstract/25/Supplement_1/S61/5308303?redirectedFrom=fulltext" target="_blank" >https://academic.oup.com/ibdjournal/article-abstract/25/Supplement_1/S61/5308303?redirectedFrom=fulltext</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/ibd/izy393.141" target="_blank" >10.1093/ibd/izy393.141</a>
Alternative languages
Result language
angličtina
Original language name
MIR-21-5P and MIR-146A-5P are deregulated in inflamed terminal ileum of treatment-naive pediatric patients with Crohn's disease
Original language description
Background Deregulation of intestinal microRNAs (miRNAs) have been reported in adult and, in the last years, also in pediatric patients with Crohn's disease (CD). We performed a literature search and chose 4 miRNAs from five relevant studies as candidates for an independent validation (miR-21-5p, miR-31-5p, miR-146a-5p, miR-155-5p). The goal of this study was to verify deregulated expression of the candidate miRNAs in inflamed terminal ileum of treatment-naïve pediatric patients with CD. Methods We collected formalin-fixed paraffin-embedded terminal ileum biopsies from treatment-naive pediatric patients with CD (n=20, median age 15 (range 10-18) years, 9 females, 11 males) and matched controls (pediatric patients undergoing endoscopy for suspicion of polyp or IBD; N=10). Total RNA enriched for small RNAs was isolated, and expression levels of candidate miRNAs were detected by use of quantitative real-time PCR. Levels of the candidate miRNA were normalized to match the levels of the reference miRNA, and statistically evaluated. Results We confirmed that miR-21-5p and miR-146a-5p have significantly higher expression in the inflamed mucosa of terminal ileum of CD patients in comparison to the terminal ileum of healthy controls (P=0.047, AUC=0.732, and P=0.046, AUC=0.768; respectively). We further developed a model based on the combination of miR-21-5p and miR-146a-5p expression, which enabled the identification of CD patients with sensitivity 86% and specificity 75% (AUC = 0.898). We were not able to validate deregulated expression of miR-31-5p and miR-155-5p in pediatric CD patients.Conclusions To our knowledge, this pilot study is the first one to evaluate the candidate miRNA expression levels exclusively in the terminal ileum of pediatric CD patients. We confirmed some of the previous observations (e.g. increased levels of inflammatory miR-21-5p and miR-146-5p), but surprisingly miR-155-5p and miR-31-5p, previously observed to be increased in the inflamed colonic biopsies, were not deregulated in terminal ileum of our pediatric CD patients. Further research is necessary to clarify the pathophysiological roles of these miRNAs in pediatric CD.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30219 - Gastroenterology and hepatology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů